ZYX and Bloom syndrome: As revealed by IHC and western blotting, the protein level of Zyxin was upregulated (4.6-fold) in the BLM-treated WT mice and significantly downregulated (7.0-fold) in the BLM-treated Zyxin-/- mice (Figures 2B-D).